TFRC and diffuse large B-cell lymphoma: Elevated Tfr characterized as CD4+CXCR5+FoxP3+ were found in (1) lower stage DLBCL patients compared to higher stage patients and (2) in DLBCL patients who remained in remission following chemoimmunotherapy compared to those who relapsed (97).